# SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke

> **Open Intelligence Dossier** · First detected: 2026-08-29 01:07 UTC · Category: Health

## Executive Summary
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke" is generating significant coverage in the Health category, with 12 articles from 9 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Seoul Economic Daily, Korea Biomedical Review, Medscape and News-Medical. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Seoul Economic Daily | Blood Thinners Cut Stroke Risk in Moderate-Risk Heart Patients | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPYlVESDZhRHJUeTVVZ1I1U1NoMDNWVnM5TmRMV2VnaU4wUEpfcWlnUTBYNjYycWxQeDBjeU85WUpabEpmcUVnWFl0OUsxejRpczFDSXU1OVZhN3BSSEd1LUJ5dWVHb1NfR3pYM2JFSDBKQlFxdFRGY194aFcwSElYSHE4OUI5ZnAxWGhaaXV3ck9jM0laNGNPSkxYMA?oc=5) |
| Korea Biomedical Review | [ESC 2026] SINGLE-AF study closes evidence gap on DOACs in intermediate-risk AF | [Source Link](https://news.google.com/rss/articles/CBMibkFVX3lxTE9jOVQ0Z200end6WWNEcFR1YnVqVkFVNmpMbzdib3c5aVhNOVFYSGd4b0I0VTV0RzhWd1JndmRTZHhxc2JUNy1HZXdJdUdZT0RrSldoSVI1alRqYkNDSHVEVkdSU21BS0pKdDRlcW5n0gFyQVVfeXFMUDBKa3Q5V1hKN2twaHhTRUVPQjFQam11YzdIMENxTUp0Zi1SZXQwcjU3MkFVVGRmN3BWNGs2Q01zMEdqNlY4ODdOZWJHTXdCc2ZTMVNJOUNIYThPWC1SdFl6bS1vVHJoMVBvVTFGYXg0azdR?oc=5) |
| Medscape | To Anticoagulate or Not in Intermediate-Risk AF: The SINGLE-AF Trial | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNR1hGS25jUmFvVjV2S0pxNjd2cnc0eGdlbVd2M0FKNFFnYTRZNlJ6dTNrODdOM3JGeE9MQ2pzS1pXSDh4UHNQb2hvVnBQeWVReEFPOXMtMEFxa3JvMGRQUnhjQWZFa1p4QmlxY18yVUlGdkNtSEp1eExhVldmRERSSFl0Y0NOWnFjQXBlRGx5ZmlOSHhyTzV6Vy1HN2ZqXzNEam0xTk4tM0lZM00?oc=5) |
| News-Medical | New findings do not support the use of edoxaban in AF patients after intracranial hemorrhage | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaE9WOU9IcGFzd2ozMkQ4UHBIS19ZTzh3MmplbWpHd0xnRmdJLWg0UC10NlJMUTd6b0htemk2amVsT1Q4aVBhZk51cEZqejk5UHJxbDZlRnpEX2ZCa2JlUzJHVTFaa3VJWU5GM1NxX0dKYmdoaVZMZFZYREYxZW15MnVFLVNEcWVfM05NT0pWVU9oS1dJYUNyQmZlUEFnMi13UUw0TnduTC1oYk1OcW1naVZqanZxNnpUQTNSdkxaR2g3bjRLZDRmTDUyV2V0M3IwRE1mc25Ibw?oc=5) |
| HCPLive | ENRICH-AF: Edoxaban Increases Bleeding Without Reducing Stroke | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxNZEpxYkpFNjNDb2JXSzE1TC1UQWNBMFFGcUJwZ01oUTZNeHNYbXFMNHgwSmpNNWZNMlNNZldEc0JNbi01djVIWDZGbDAtZXdzSTlnLVExYl9PMXRaYlhpbjJwRmlDaGlITVhGYUVIckJkelMzOURLTXdqS3pVMFRlNm1QT0w1SDNVdUhDSGtpTnozeUNR?oc=5) |
| Medical Xpress | People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNaTZOR09WbzhlbkhtVDM5MEIybWlPVHBQWmdOS1ltNmV5akZvZUpVOU9aby1zY19fZndIb0hmYzF2QVJkRkVsTmJyeGVYWE9aaGZOTlpraVRFWEhGTEtGWXhQbzJwaVFGVFpyQXd1czBMSkxNYXV1VDJULUVVTWVQTTJ1WTJjRGdDUE1nZUxEOTNoTk15Rmc?oc=5) |
| TCTMD.com | DOACs Benefit AF Patients With Intermediate Stroke Risk: SINGLE-AF | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxPLW1XcU5qUmFaOHZfVkhueGFPOUZZcXlRY1BxUDhNckxRWV83SmdBQ094bEczeXF0akgzOGh4ZnZaYU1MUDlUU29YVmlzZFNkX2ExbVdodUZrSlpYdS1TR2FiQjhKaFZSYjlDVmtwV000UnEyc25Qa2FXSnE1OGRWLVRKVEtsdmlobXZSaS1qM04?oc=5) |
| MedPage Today | First Major Trial Win for Contemporary DOACs in Lower-Risk Afib | [Source Link](https://news.google.com/rss/articles/CBMiZkFVX3lxTFA0YVVDZHN2SFV1eFczVG9oanQ3TEFSQVV4OGNxS0xRWVlwMXhOajhLX0VzRUxyLXhuSzk0SHE5eXZDQzZZZzJoTktFU0dibGtfeEFkU3M0NHNpWkdydFkyMWp2Ym5XUQ?oc=5) |
| HCPLive | SINGLE-AF: Oral Anticoagulants Reduce Risk of Stroke in Patients With AF | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxObWlqbHZaYmVpWDhlYXNOUTJlY0FXZVE4a1E0WHkxN2N6WG56ZzNDMjBpck5xbWdWWWFVQ3pGUkUyT0FzeFdLbzFOUlFUUnJRSGkzOGdBdldpS052c0pka1Vid2lUN2xwOEJnbG1IaE1ZWlBzUWRuRzRFRVI5ekFidG9rejNkYVNJZ3ZmTW1tMGZOSEtJRm1hZGFUMkttVVVYUnc?oc=5) |
| News-Medical | Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZU1USTdaOWJuYjZILVVKTkFaZHBaT2RuQ0xPVE1kSjdoX1dsMmVaNVI4U0ozTnl4cmVSZkJCakFCX0R4Y0ZmNVBGT1lmUFlpWklJSXU2ZFNBd3Z4NUJFT3BFakl4emo4c0FqUm5VREVQck5jZEQ2MG00UGhSeHVPU3k0M0JfbDkzSUtpSGc1Z3VMUExyNXh5QUVaR2NOc3hGRTVuTVdaamNVa3puVklnWUpaZGZ2SVFoVWlxOUVBcWwzV2lKZDFhazAwN2p1eWUzQWc4?oc=5) |
| Medscape | DOACs Benefit AF Patients With Intermediate Stroke Risk | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPRDhoekF4SkxzWlZMY2ZBOHowUkMycUhncDJNRVBFM1JNOFV1QTQybXlNRDlGMGN6NWplMkpvZVN0TVdmYVpRNFkwOEpVUXpkOHZ6X0xHR1NCOWoyWHVDbnJ1ZUprZzJjN01WSXdrS1g3d0psN1hvWkY1NV84ZVFLTmZraENHdU94Ry11XzRHclVsdGx3NWVDdmM4T18wR1NFOXVhSVJhZlNNcmdmSmp3?oc=5) |
| American College of Cardiology | SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPd0xVTjhMblBZbW1UaWhFd0pCTEZ0QUt2WHhSY1F0Z2hmeS1DWUJEVjdFN2xoM09XRlBDZW82VGIyOGFySHh3WE9rZmhQdE5RakFqdlFDSDJJSzVQendWdnU5dDFBMlVOcVVFMGxLTXI3cmlDQmlCYWNPc01qYnZkYlZxT05rYWNqZWY1ci1SR010X0VyOWJmd0FTdw?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-29/single-af-doac-therapy-vs-no-anticoagulation-in-afib-patients-at-intermediate*